Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
10
NMPA:10
Drug Approvals
Potassium Citrate Sustained-release Tablets
- Product Name
- 枸橼酸钾缓释片
- Approval Number
- 国药准字H20249383
- Approval Date
- Nov 15, 2024
NMPA
Potassium Citrate Sustained-release Tablets
- Product Name
- 枸橼酸钾缓释片
- Approval Number
- 国药准字H20249384
- Approval Date
- Nov 15, 2024
NMPA
Procaterol Hydrochloride Oral Solution
- Product Name
- 盐酸丙卡特罗口服溶液
- Approval Number
- 国药准字H20244738
- Approval Date
- Aug 27, 2024
NMPA
Procaterol Hydrochloride Oral Solution
- Product Name
- 盐酸丙卡特罗口服溶液
- Approval Number
- 国药准字H20244739
- Approval Date
- Aug 27, 2024
NMPA
Oxcarbazepine Oral Suspension
- Product Name
- 奥卡西平口服混悬液
- Approval Number
- 国药准字H20244305
- Approval Date
- Jun 28, 2024
NMPA
Oxcarbazepine Oral Suspension
- Product Name
- 奥卡西平口服混悬液
- Approval Number
- 国药准字H20244304
- Approval Date
- Jun 28, 2024
NMPA
Bisoprolol Fumarate and Amlodipine Besilate Tablets
- Product Name
- 比索洛尔氨氯地平片
- Approval Number
- 国药准字H20243459
- Approval Date
- Apr 7, 2024
NMPA
Norepinephrine Bitartrate Injection
- Product Name
- 重酒石酸去甲肾上腺素注射液
- Approval Number
- 国药准字H20234333
- Approval Date
- Oct 18, 2023
NMPA
Clinical Trials
No trials found
News
No news found